![]() Angionetics Angionetics is a company focused on the late-stage clinical development and commercialization of Generx, an angiogenic gene therapy product candidate designed for medical revascularization for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. | |||
Founding Date | Founding Date N/A | Founding Date 2016 | Founding Date 2018 |
Type | Type Subsidiary | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Stevenage, GB HQ London, GB Ambler, US | Locations Seattle, US HQ |
Employees | Employees N/A | Employees 502% increase | Employees 47 |

Gyroscope Therapeutics Holdings is an ophthalmology company.
View companyVariant Bio is a biotechnology company that develops human genetic diversity therapies.
View company